dm+d

108914001

Articles

What issues should be considered in patients with peanut allergy requiring a medicine containing soya?

16 October 2020Peanut and soya belong to the same plant family, so there is concern about cross-sensitivity. This Medicines Q&A (updated April 2020) discusses the issues to…

Safety in Lactation: Systemic preparations for eczema and psoriasis

7 January 2019Drugs used orally or parenterally for severe eczema and psoriasis have a varied pharmacology, mainly either modifying the immune response to the disease or modifying…
Search Articles

Medicine Compliance Aid Stability

NeotigasonActavis UK Ltd

Actavis UK Ltd
Neotigason
Capsules 10mg, 25mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
There are no theoretical concerns with the product being stored for up to 28 days.
24 September 2015

Lactation Safety Information

Topical psoriasis preparation / corticosteroid if appropriate
Very limited published evidence of safety
Long half-life increases risk of accumulation in breastfed infants
Risk to breastfed infant unknown but high risk of foetal damage if mother is not following contraception guidelines
15 September 2019